These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38549260)

  • 1. The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution.
    Kachanov A; Kostyusheva A; Brezgin S; Karandashov I; Ponomareva N; Tikhonov A; Lukashev A; Pokrovsky V; Zamyatnin AA; Parodi A; Chulanov V; Kostyushev D
    Med Res Rev; 2024 Sep; 44(5):2112-2193. PubMed ID: 38549260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer.
    Arjomandnejad M; Dasgupta I; Flotte TR; Keeler AM
    BioDrugs; 2023 May; 37(3):311-329. PubMed ID: 36862289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and toxicity of AAV gene therapy.
    Ertl HCJ
    Front Immunol; 2022; 13():975803. PubMed ID: 36032092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions.
    Masat E; Pavani G; Mingozzi F
    Discov Med; 2013 Jun; 15(85):379-89. PubMed ID: 23819952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
    Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
    Elife; 2021 Oct; 10():. PubMed ID: 34664552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles.
    Smith JK; Agbandje-McKenna M
    PLoS Pathog; 2018 May; 14(5):e1006929. PubMed ID: 29723270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
    Liu Y; Siriwon N; Rohrs JA; Wang P
    Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog.
    Rapti K; Grimm D
    Front Immunol; 2021; 12():753467. PubMed ID: 34777364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
    Lotfinia M; Abdollahpour-Alitappeh M; Hatami B; Zali MR; Karimipoor M
    Clin Exp Med; 2019 Aug; 19(3):289-298. PubMed ID: 31054018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redirecting AAV vectors to extrahepatic tissues.
    Asokan A; Shen S
    Mol Ther; 2023 Dec; 31(12):3371-3375. PubMed ID: 37805712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to adeno-associated virus vectors.
    Zaiss AK; Muruve DA
    Curr Gene Ther; 2005 Jun; 5(3):323-31. PubMed ID: 15975009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming innate immune barriers that impede AAV gene therapy vectors.
    Muhuri M; Maeda Y; Ma H; Ram S; Fitzgerald KA; Tai PW; Gao G
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Search of Adeno-Associated Virus Vectors With Enhanced Cardiac Tropism for Gene Therapy.
    Sasaki N; Kok CY; Westhaus A; Alexander IE; Lisowski L; Kizana E
    Heart Lung Circ; 2023 Jul; 32(7):816-824. PubMed ID: 37451880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications.
    Lugin ML; Lee RT; Kwon YJ
    ACS Nano; 2020 Nov; 14(11):14262-14283. PubMed ID: 33073995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
    Verdera HC; Kuranda K; Mingozzi F
    Mol Ther; 2020 Mar; 28(3):723-746. PubMed ID: 31972133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
    Rodríguez-Márquez E; Meumann N; Büning H
    Expert Opin Biol Ther; 2021 Jun; 21(6):749-766. PubMed ID: 33331201
    [No Abstract]   [Full Text] [Related]  

  • 18. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
    Louis Jeune V; Joergensen JA; Hajjar RJ; Weber T
    Hum Gene Ther Methods; 2013 Apr; 24(2):59-67. PubMed ID: 23442094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver directed adeno-associated viral vectors to treat metabolic disease.
    Chuecos MA; Lagor WR
    J Inherit Metab Dis; 2024 Jan; 47(1):22-40. PubMed ID: 37254440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.
    Wagner HJ; Weber W; Fussenegger M
    Adv Sci (Weinh); 2021 May; 8(9):2004018. PubMed ID: 33977059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.